Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of D-PLEX plus standard prophylactic antibiotics versus standard care alone for prevention of sternal infections after cardiac surgery
2019-002207-17Phase 3Terminated
- Sponsor
- PolyPid Ltd.
- Start
- May 2020
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in surgical site infection (SSI) and sternal wound infection comparing D-PLEX + standard of care with Standard of care only (2 arms). Primary endpoint: Sternal wound infection rate within 90 days. Started May 2020; status: terminated.
02
Drugs
D-PLEX100
03
Conditions
surgical site infection (SSI)sternal wound infection
Beyond the preview
Go deeper on 2019-002207-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002207-17.